Literature DB >> 17434612

How to image Kawasaki disease: a validation of different imaging techniques.

Sophie Mavrogeni1, George Papadopoulos, Evangelos Karanasios, Dennis V Cokkinos.   

Abstract

Kawasaki disease contributes to coronary artery aneurysm in 25% of patients. Cardiovascular imaging has an important role in diagnosis and follow-up of these cases. Echocardiography is the bedside technique of choice during the acute phase of the disease. MRI can be a valuable tool especially in adolescents, where sometimes echocardiography fails to detect coronary abnormalities and it has also the advantage of simultaneous perfusion, function and viability evaluation. If MRI is not available, a combination of echocardiography and SPECT gives an overview of anatomy, function and perfusion. MSCT is of limited value for follow-up because of radiation and the misleading data due to coronary calcifications. X-ray coronary angiography is kept mainly for cases where an invasive procedure should be performed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434612     DOI: 10.1016/j.ijcard.2007.02.035

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

1.  Coronary periarteritis in a patient with multi-organ IgG4-related disease.

Authors:  Yueyang Guo; David Ansdell; Sharon Brouha; Andrew Yen
Journal:  J Radiol Case Rep       Date:  2015-01-31

2.  Predictors of coronary artery visualization in Kawasaki disease.

Authors:  Renee Margossian; Minmin Lu; L LuAnn Minich; Timothy J Bradley; Meryl S Cohen; Jennifer S Li; Beth F Printz; Girish S Shirali; Lynn A Sleeper; Jane W Newburger; Steven D Colan
Journal:  J Am Soc Echocardiogr       Date:  2011-01       Impact factor: 5.251

3.  Application of prospective ECG-triggered dual-source CT coronary angiography for infants and children with coronary artery aneurysms due to Kawasaki disease.

Authors:  Y Duan; X Wang; Z Cheng; D Wu; L Wu
Journal:  Br J Radiol       Date:  2012-08-29       Impact factor: 3.039

4.  Adolescent Kawasaki disease: usefulness of 64-slice CT coronary angiography for follow-up investigation.

Authors:  Iacopo Carbone; David Cannata; Emanuela Algeri; Nicola Galea; Alessandro Napoli; Andrea De Zorzi; Giovanna Bosco; Rita D'Agostino; Leon Menezes; Carlo Catalano; Roberto Passariello; Marco Francone
Journal:  Pediatr Radiol       Date:  2011-06-30

5.  Assessment of coronary artery lesions in children with Kawasaki disease: evaluation of MSCT in comparison with 2-D echocardiography.

Authors:  Yanlin Xing; Hong Wang; Xianyi Yu; Rui Chen; Yang Hou
Journal:  Pediatr Radiol       Date:  2009-08-11

Review 6.  [Vasculitis in the trunk: Imaging patterns of typical organ manifestations due to primary vasculitis of small and medium sized vessels].

Authors:  H Strube; C Becker-Gaab; M Reiser; M Treitl
Journal:  Radiologe       Date:  2010-10       Impact factor: 0.635

7.  Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions.

Authors:  Fabienne Mueller; Walter Knirsch; Paul Harpes; René Prêtre; Emanuela Valsangiacomo Buechel; Oliver Kretschmar
Journal:  Clin Res Cardiol       Date:  2009-06-05       Impact factor: 5.460

8.  Giant coronary aneurysm caused by Kawasaki disease: consistency between catheter angiography and electrocardiogram gated dual-source computed tomography angiography.

Authors:  Eun-Ha Hwang; Jung-Ki Ju; Min-Jung Cho; Ji-Won Lee; Hyoung-Doo Lee
Journal:  Korean J Pediatr       Date:  2015-12-22

Review 9.  The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease.

Authors:  Sophie Mavrogeni; George Papadopoulos; Tarique Hussain; Amedeo Chiribiri; Rene Botnar; Gerald F Greil
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-15       Impact factor: 2.357

10.  Coronary artery involvement in pediatric Takayasu's arteritis: Case report and literature review.

Authors:  Shaun Mohan; Sarah Poff; Kathryn S Torok
Journal:  Pediatr Rheumatol Online J       Date:  2013-02-12       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.